BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 72701)

  • 1. Hepatitis B surface antigen and alpha-fetoprotein in patients with hepatocellular carcinoma.
    Chen DS; Sung FL
    Gastroenterology; 1978 Jan; 74(1):163-4. PubMed ID: 72701
    [No Abstract]   [Full Text] [Related]  

  • 2. [The occurrence and significance of the presence of alpha fetoprotein (AFP) and Australia antigen (HBsAg) in the serum of 392 patients with chronic disease and primary malignant neoplasms of the liver].
    Stajić M; Milosavljević J
    Acta Med Iugosl; 1978; 32(3):243-51. PubMed ID: 80098
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis B antigen and alpha fetoprotein in the sera of patients with hepatocellular carcinoma.
    Rajagopalan N; Sama SK; Krishnamurthy L; Gandhi G; Nayak NC
    Indian J Med Res; 1977 Jan; 65(1):95-100. PubMed ID: 68001
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serum alpha-fetoprotein and hepatitis B surface antigen in patients with hepatocellular carcinoma (author's transl)].
    Kao MC; Yin SJ; Lee SC; Lin CY; Cheng TC; Fong MS
    Taiwan Yi Xue Hui Za Zhi; 1980 Nov; 79(11):1032-7. PubMed ID: 6166727
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunologic and immuno-histochemical determination of alpha l-fetoprotein and HBs antigens in hepatocellular carcinoma].
    Perisić-Savić M; Perisić V; Sinćić M; Janev A; Nastić-Mirić D
    Srp Arh Celok Lek; 1981; 109(5-6):775-82. PubMed ID: 6179170
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis B antigen, alpha-fetoglobulins and primary hepatocellular carcinoma in Ethiopia.
    Tsega E; Gold P; Shuster J; Whittemore B; Lester FT
    J Trop Med Hyg; 1976 Oct; 79(10):230-4. PubMed ID: 64619
    [No Abstract]   [Full Text] [Related]  

  • 7. [Primary hepatocellular carcinoma. Relation between serum and liver alpha fetoprotein, B virus infection, histology].
    Maggi G; Bighellini K; Borghi L
    Minerva Dietol Gastroenterol; 1985; 31(4):627-33. PubMed ID: 2418386
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis B surface antigenemia in patients with hepatocellular carcinoma in relation to clinical course and alpha-fetoprotein.
    Kubo Y; Okuda K; Shimokawa Y; Arishima T; Nagata E
    Gastroenterology; 1977 Jun; 72(6):1213-6. PubMed ID: 67061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum alpha-fetoprotein and hepatitis B antigen in subjects with hepatoma in south India.
    Hill PG; Johnson S; Madanagopalan N
    Indian J Med Res; 1977 Apr; 65(4):482-7. PubMed ID: 71266
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of hepatitis B viral markers in hepatitis B endemic areas of China.
    Luo S; Ye FS; Mo ZC; Su YX; He JS; Zhou CQ; Tong MJ; Henderson BE; Yu MC
    Chin Med J (Engl); 1988 Sep; 101(9):654-8. PubMed ID: 2466618
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary hepatocellular carcinoma with hepatitis B virus infection in a 16-year-old noncirrhotic patient.
    Gasser RW; Judmaier G; Zur Nedden D; Aufschnaiter M; Hofstaedter F
    Am J Gastroenterol; 1983 May; 78(5):305-8. PubMed ID: 6189392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
    Okuda H; Obata H; Motoike Y; Hisamitsu T
    Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B surface antigen and alpha-1-fetoprotein in hepatoma. Reports of 157 cases.
    Pongpipat D; Suvatte V; Plengvanit U; Chinapak O; Bunyaphisit S; Assateerawatts A
    J Med Assoc Thai; 1983 Nov; 66(11):696-9. PubMed ID: 6200559
    [No Abstract]   [Full Text] [Related]  

  • 14. Distribution of five antigens in hepatocellular carcinoma.
    Thung SN; Gerber MA; Sarno E; Popper H
    Lab Invest; 1979 Aug; 41(2):101-5. PubMed ID: 88543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of hepatocellular carcinoma performed by searching for serologic tumor markers].
    de Oliveira e Silva A; Roldan-Molina F; dos Santos TE; Santo GC; Miranda MP; Genzini T; Neves LB; D'Albuquerque LA
    Arq Gastroenterol; 1990; 27(2):83-94. PubMed ID: 1709803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-specific tumoral markers in hepatocellular carcinoma.
    Stanciu L; Dumitraşcu D; Radu D; Badea R
    Med Interne; 1990; 28(2):139-44. PubMed ID: 1702896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alphafetoprotein levels measured by radioimmunoassay in various liver malignancies.
    Chang FY; Chen TC; Fong MS; Lin S; Yeh SH
    Taiwan Yi Xue Hui Za Zhi; 1982 Feb; 81(2):224-31. PubMed ID: 6178794
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pathological and serological investigation on early primary hepatocellular carcinoma and its liver disease background (author's transl)].
    Sun ZT; Wang NJ; Xia QJ; Wang LQ; Zhang YL
    Zhonghua Zhong Liu Za Zhi; 1979; 1(1):13-19. PubMed ID: 95340
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum alphafoetoprotein, hepatitis B virus infection and primary hepatocellular carcinoma in Nigerians.
    Ola SO; Olubuyide IO; Ayoola EA
    East Afr Med J; 1994 Dec; 71(12):782-3. PubMed ID: 7535684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of a hepatoma-liver antigen in the sera of patients with primary hepatocellular carcinoma.
    Oon CJ; Yo Sui Lan
    Singapore Med J; 1979 Jun; 20(2):317-22. PubMed ID: 92056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.